Opioid maker Purdue Pharma’s global counterparts make millions overseas
A first-of-its-kind analysis conducted as part of an investigation by journalists in eight countries found that some of the same tactics used to persuade a generation of U.S. doctors that potent painkillers could be safely prescribed have been used abroad.
View original article
Contributor: David Ovalle, McKenzie Beard
